Medicare expands coverage to wigs for cancer and autoimmune patients
H.R. 7546 — To amend title XVIII of the Social Security Act to provide coverage for wigs as durable medical equipment under the Medicare program, and for other purposes. · Filed by Jim McGovern (D-MA) · 7 cosponsors · Introduced Feb 12, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare coverage to include wigs (called 'cranial prostheses') as durable medical equipment for patients with hair loss caused by medical conditions like cancer, autoimmune diseases, or chemotherapy. A dermatologist, oncologist, or attending physician must certify in writing that the wig is medically necessary as part of treatment. Medicare will only pay for wigs that meet this certification requirement.
Why we flagged it
The bill's sole operative mechanism is to expand Medicare's definition of covered durable medical equipment to include medically certified wigs (cranial prostheses) for patients with hair loss from serious medical conditions. This is a straightforward benefit expansion with a medical-necessity gate.
What the text implies
- Certification requirement places administrative burden on physicians; practices may need to develop new documentation workflows to comply with Medicare's written-certification mandate.
- Coverage may incentivize manufacturers to market wigs as medical devices rather than cosmetic products, potentially shifting regulatory classification and pricing strategies in the wig industry.
The full analysis lists 3 implications of this text.
Who stands to gain
Medicare beneficiaries (reduced out-of-pocket costs); wig manufacturers and suppliers (expanded market access to Medicare reimbursement)